Translational Development Acquisition Corp. (TDACW) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2021
Loading P/E history...
TDACW Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Translational Development Acquisition Corp. (TDACW) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.10 and trailing twelve-month earnings per share of $0.28.
The current P/E is 102% below its 5-year average of 1.3x. Over the past five years, TDACW's P/E has ranged from a low of 0.3x to a high of 5.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.1x, TDACW trades at a 100% discount to its sector peers. The sector includes 775 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, TDACW trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TDACW DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TDACW P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $16M | 9.7Lowest | - | -4% | |
| $30B | 22.8 | 0.56Best | +5% | |
| $10B | 13.1 | 1.87 | +29%Best | |
| $12B | 28.1 | 0.88 | +21% | |
| $1B | 24.9 | - | -4% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
TDACW Historical P/E Data (2018–2021)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2021 Q3 | $2.03 | $1.20 | 1.7x | +27% | |
| FY2020 Q2 | $0.46 | $0.09 | 5.1x | +281% | |
| FY2020 Q1 | $0.10 | $0.25 | 0.4x | -71% | |
| FY2019 Q4 | $0.10 | $0.36 | 0.3x | -79% | |
| FY2019 Q3 | Mon Sep 30 2019 00:00:00 GM | $0.15 | $0.45 | 0.3x | -75% |
| FY2019 Q2 | Sun Jun 30 2019 00:00:00 GM | $0.15 | $0.46 | 0.3x | -75% |
| FY2019 Q1 | Sun Mar 31 2019 00:00:00 GM | $0.16 | $0.36 | 0.4x | -67% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $0.30 | $0.25 | 1.2x | -10% |
| FY2018 Q3 | Sun Sep 30 2018 00:00:00 GM | $0.29 | $0.13 | 2.2x | +68% |
Average P/E for displayed period: 1.3x
See TDACW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TDACW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TDACW vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonTDACW — Frequently Asked Questions
Quick answers to the most common questions about buying TDACW stock.
Is TDACW stock overvalued or undervalued?
TDACW current P/E: -0.0x. 5-year average P/E: 1.3x. Percentile: N/A.
How does TDACW's valuation compare to peers?
Translational Development Acquisition Corp. P/E of -0.0x compares to sector median of 13.1x. Sector comparison provides relative valuation context.
What is TDACW's PEG ratio?
TDACW PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2021.